share_log

Morgan Stanley Initiates Coverage On Mural Oncology With Overweight Rating, Announces Price Target of $13

Morgan Stanley Initiates Coverage On Mural Oncology With Overweight Rating, Announces Price Target of $13

摩根士丹利以增持评级启动对壁画肿瘤学的报道,宣布目标股价为13美元
Moomoo 24/7 ·  04/04 06:39

Morgan Stanley analyst Judah Frommer initiates coverage on Mural Oncology (NASDAQ:MURA) with a Overweight rating and announces Price Target of $13.

摩根士丹利分析师犹大·弗罗默以增持评级启动了对Mural Oncology(纳斯达克股票代码:MURA)的报道,并宣布目标股价为13美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发